Monash Institute of Pharmaceutical Science (MIPS) researchers Dr Karen Gregory and Dr John Quinn have been awarded 2017 Australian Research Council (ARC) Future Fellowships and Professor Colin Pouton, Professor Nico Voelcker and Dr Roey Elnathan
Melbourne researchers have developed a new drug delivery strategy able to block pain within the nerve cells, in what could be a major development of a long lasting, and immediate, treatment for pain.
In May 2017, Germany’s peak research funding body, the DFG, announced it would renew funding of an International Research Training Group (IRTG) between Monash University and Justus-Liebig University (JLU), Germany. Dr Betty Exintaris from Drug
Inflammation is part of the body’s natural healing process, but when it gets out of control it can cause disease. Monash Institute of Pharmaceutical Sciences (MIPS) researchers, in collaboration with researchers from the
Bob Blouin, Dean of Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, receives honorary degree from Monash University
In a graduation ceremony earlier today, Monash University has conferred an honorary doctorate upon Professor Robert A. “Bob” Blouin, Dean of the UNC Eshelman School of Pharmacy at the University of North Carolina (UNC) at Chapel Hill.
Monash University drug discovery research has led to a change in editorial policy of the world’s largest scientific society, in a move that could save government and industry millions of dollars a year in preventing dead-end research.
Researcher from the Monash Institute of Pharmaceutical Sciences elected to the Australian National Academy of Science
Professor Thomas Davis has been elected as a Fellow of The Australian National Academy of Science. Professor Davis is an internationally renowned polymer chemist and nanotechnologist.